Trial Profile
A prospective, multicenter, randomized, efficacy and safety trial of mirodenafil in patients with benign prostatic hyperplasia and erectile dysfunction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Mirodenafil (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction
- Focus Adverse reactions; Therapeutic Use
- 18 May 2016 New trial record
- 10 May 2016 Results presented at the 111th Annual Meeting of the American Urological Association